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Functional foods currently represent a significant portion of the food market 
(Siró, Kápolna, Kápolna, & Lugasi, 2008). It is believed that the growth of the 
functional food market is related to increasing population awareness about the 
close relationship between food and health (Lähteenmäki, 2013). Functional 
foods present bioactive components in their composition capable of optimizing 
the metabolic and/or physiological functioning of the organism, resulting in 
disease prevention, especially chronic non-degenerative diseases (Gul, Singh, & 
Jabeen, 2016; Tur & Bibiloni, 2016). Among components that give food 
functional classifications are antioxidant vitamins, phytosterol, omega 3, fiber, 
prebiotics and probiotics (Dias, Botrel, Fernandes, & Borges, 2017; Schieber, 
2012).  
Probiotics are living microorganisms that, when administered in suitable 
amounts, confer benefits to host health (FAO/WHO, 2002). The main genera 
used as probiotics are Lactobacillus and Bifidobacterium (Sharma & Devi, 2014). 
When ingested in sufficient amounts, probiotics present benefits through a variety 
of mechanisms, including decreases in the number of pathogenic microorganisms 
through competitive exclusion (competition for binding sites and nutrients) and 
bacteriocin production (Niamah, 2010; Hegarty et al., 2016), stimulation of the 
immune system (Ashraf & Shah, 2014; Castillo, de Moreno de LeBlanc, 
Galdeano, & Perdigón, 2012), vitamin synthesis (LeBlanc et al., 2011), 
production of short chain fatty acids (acetate, propionate and butyrate) through 
fiber fermentation (Gibson, 2004), and lactose digestion, reducing the effects of 
lactose intolerance (Staudacher, 2015). 
Currently, probiotic-containing foods represent an important share of the 
functional food market (Begum et al., 2017), with emphasis on the dairy industry 
(Granato, Branco, Cruz, Faria, & Shah, 2010; Vijaya Kumar, Vijayendra, & 
Reddy, 2015). The development of these foods involves several challenges. The 
microorganism must be capable of surviving the adverse conditions inherent to 
food product processing and storage (Champagne, Gardner, & Roy, 2005). 
However, before planning the development of probiotic-containing food, 
challenges involving the proper selection of these microorganisms must be 
overcome. A series of criteria involving safety, functional and technological 
characteristics must be met for a microorganism to be considered probiotic 
(Mattila-Sandholm et al., 2002).  
Probiotic selection begins with the precise identification of the microorganism at 
the genus, species and strain levels. It is recommended that the microorganism be 
of human origin, due to the greater propensity to adapt to the human intestine, 
also considering, the greater possibility of adhesion to intestinal epithelial cells 
(FAO/WHO, 2002; Shewale, Sawale, Khedkar, & Singh, 2014). The 
microorganism must be completely safe for human ingestion, with a non-
pathogenic history and no antibiotic resistance gene transfer capabilities 
(FAO/WHO, 2002; Havenaar, Brink, & Huis In ’t Veld, 1992). In addition, the 
probiotic candidate must be able to withstand the adverse conditions of the 
gastrointestinal tract, including contact with gastric acid and bile acids in the 
stomach and intestine, respectively (Tuomola, Crittenden, Playne, Isolauri, & 
Salminen, 2001). It is important that the microorganism display the ability to 
colonize the human intestine, albeit transiently, through adhesion to the intestinal 
epithelium (FAO/WHO, 2002; Shewale, Sawale, Khedkar, & Singh, 2014). 
Finally, probiotics are expected to exhibit antimicrobial activity against 
potentially pathogenic bacteria, resistance to antibiotics and be capable of 
stimulating the host's immune system (Saarela, Mogensen, Fondén, Mättö, & 
Mattila-Sandholm, 2000). After fulfilling these criteria, in vivo tests are applied 
to determine the possible beneficial effects on the maintenance or recovery of 
human health.  
 
Desirable characteristics for probiotic microorganisms were evaluated in Lactobacillus rhamnosus 64 and Lactobacillus paracasei 
LP11. Both strains were tested for resistance to lysozyme and simulated gastrointestinal fluids, determination of cell wall 
hydrophobicity, evaluation of antibiotic susceptibility, antagonist activity against pathogens and the ability to use prebiotics. The safety 
determination was performed by an in vivo test, where the occurrence of bacterial translocation to liver was evaluated after daily oral 
administration of the strains for 10 days to mice. All results were promising, with the exception of resistance to simulated 
gastrointestinal fluids, that was unsatisfactory, with a decrease in viable cell concentrations of up to 5.08 log CFU/mL. The 
hydrophobicity profile of the strains ranged between 8.47 and 19.19%. Both showed satisfactiry resistance to lysozyme, with survival 
rates above 80%, strains were able to antagonize Escherichia coli V517, Salmonella enteritidis OMS-Ca, Staphylococcus aureus 76 and 
Listeria monocytogenes ATCC 15313, and displayed satisfactory use of lactulose, inulin and P95 raftilose as prebiotics. No bacterial 
translocation was observed after the administration of the strains to mice. The results obtained herein justify the use of L. rhamnosus 64 
and L. paracasei LP11 in new investigations for the future application of these microorganisms as probiotics. 
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Considering that microorganism characterization is indispensable for the 
adequate development of functional foods, the aim of the present study was to 
evaluate the potential of Lactobacillus paracasei LP11 and Lactobacillus 
rhamnosus 64 as probiotic candidates by in vitro and in vivo tests. 
 




Frozen culture of commercial probiotic (Lactobacillus paracasei LP11) was 
obtained from local provider. Lactobacillus rhamnosus 64 isolated from newborn 
human feces (Vinderola et al., 2008), were evaluated herein. Before each 
analysis, freeze-dried L. paracasei LP11 and L. rhamnosus 64 frozen in MRS 
broth (de Man, Rogosa and Sharpe) were activated in MRS broth (Biokar, 
Beauvais, France) during 16 h at 37 °C under aerobic conditions. The identity of 
frozen culture of commercial probiotic manufacturer has been kept undisclosed 
for confidentiality reasons. 
 
Resistance to lysozyme 
 
The lysozyme resistance analysis was performed as described by Vizoso Pinto, et 
al. (2006) and Zago et al. (2011) with modifications. Microorganisms grown 
overnight in 10 ml of MRS broth at 37oC were centrifuged, washed twice and 
resuspended in 2 ml of phosphate buffer (0.1 M, pH 7.0). Subsequently, 10% of 
the bacterial suspension was inoculated into a sterile electrolytic solution (SEE) 
(SEE; 0.22 g/l CaCl2, 6,2 g/l NaCl, 2.2 g/l KCl, 1.2 g/l NaHCO3) in the presence 
of 100 mg/l lysozyme (Sigma-Aldrich). The control comprised the bacterial 
suspension inoculated into the SEE without lysozyme. Survival rates were 
calculated as a percentage of CFU/ml after 30 and 120 min compared to the 
counts determined at time zero. 
 
Resistance to simulated gastrointestinal fluids 
 
The in vitro evaluation of the resistance of free microorganisms to simulated 
gastric fluid (SGF) and simulated intestinal fluids (SIF) was performed according 
to the method described by Gbassi et al. (2009). The SGF was composed of 9 g/L 
sodium chloride (Synth, Diadema, Brazil) and 3 g/l pig stomach pepsin (Sigma-
Aldrich, St. Louis, USA) in distilled water with pH adjusted to 1.8 with 
hydrochloric acid. The SIF was prepared with 9 g/L sodium chloride (Synth, 
Diadema, Brazil), 10 g/L pancreatin, 9 g/L bovine trypsin (Sigma-Aldrich, St. 
Louis, MO, USA), and 3 g/L of bile salts (Oxgall, Difco, Hampshire, UK) in 
distilled water and pH adjusted to 6.5 with sodium hydroxide. The 
microorganisms were inoculated into the SGF and maintained at 37oC under 
agitation. Viable cell counts were performed in MRS at 0, 60 and 120 minutes. 
Subsequently the remaining SGF analysis material was inoculated into the SIF, 
proceeding with appropriate pH control and adjustment and viable cell counts in 




Strains were grown in 10 mL of MRS broth for 16 h at 37 °C. Cultures were 
centrifuged (6,000 rpm, 6 min) and washed twice with phosphate buffer (0.1 M, 
pH 7.0). The cultures were then suspended in the same buffer, and the optical 
density (OD) adjusted to approximately 1.0 at 560 nm. Subsequently, 0.6 ml of ƞ-
hexadecane (Sigma-Aldrich, St. Louis, USA) were added to 3.0 ml of the 
bacterial suspension and, after homogenization for 2 minutes by vortexing, the 
mixtures were incubated at 37 °C, for 1 hour, for phase separation. The lower 
aqueous phases were carefully removed with a sterile Pasteur pipette and 
absorbances (A1) were recorded at 560 nm following the method described by 
Vinderola and Reinheimer (2003) and Duary et al. (2011). The following formula 
was applied to determine the results, expressed as percentage of bacterial 
adhesion to the solvent: 
 
H % = (1 - A1/A0) × 100    (1) 
 
Where A0 is the initial adjusted absorbance and A1 is the absorbance of the 





The two strains were submitted to a sensitivity analysis for eight antibiotics 
(Laboclin, Pinhais, Brazil): cefepime (30 µg), cefoxitin (30 µg), ceftriaxone (30 
µg), erythromycin (15 µg), neomycin (30 µg), penicillin (10 µg), tetracycline (30 
µg) and vancomycin (30 µg). Susceptibility was determined according to the 
Kirby & Bauer method described in Bauer, Kirby, Sherris, & Turck (1966). A 108 
CFU/mL suspension of each strain was seeded on plates containing MRS agar. 
Subsequently, paper disks embedded with each antibiotic were placed on the 
surface of the culture medium and the plates were then incubated for 48 h at 37 
°C. After incubation, the inhibitory halos formed on each disk were measured 
with the aid of a pachymeter. The results were qualitatively analyzed, and the 
microorganisms were classified as sensitive, moderately sensitive or resistant to 
the evaluated antibiotic. 
 
In vitro antagonism 
 
The agar spot method was adopted to evaluate the in vitro antagonistic activity of 
the two lactobacilli strains (Schillinger & Lücke, 1987). Four pathogens (107 
CFU/ml) were used, namely Escherichia coli V517, Salmonella enteritidis OMS-
Ca, Staphylococcus aureus 76 and Listeria monocytogenes ATCC 15313. 
Additionally, the ability of the neutralized cell-free supernatant to promote an 
antagonistic effect was assessed according to the methodology proposed by 
Uhlman, Schillinger, Rupnow, & Holzapfel (1992) and detailed by Vizoso Pinto 
et al., (2006). Briefly, the supernatants were obtained from the overnight culture 
of L. paracasei LP11 and L. rhamnosus 64 in MRS broth maintained at 37 °C in 
aerobic conditions. After culturing, the cultures were centrifuged at 7,200 × g for 
10 minutes, neutralized with a sterile 5 M NaOH solution and the supernatants 




The capacity to use inulin, polydextrose, fructooligosaccharides and lactulose 
was evaluated, according to Zago et al. (2011). Glucose (Sigma-Aldrich) was 
used as a positive control. Initially, all prebiotics and glucose were solubilized in 
distilled water and sterilized by filtration. The strains were inoculated (1.5% 
inoculum; 106 CFU/ml)) into test tubes containing 3 ml of modified MRS broth, 
which contained 2% of each of the four prebiotics or glucose as the sole carbon 
source. The tubes were incubated at 37 °C for 24 h under aerobic conditions. The 
use of prebiotics and glucose was evaluated by measuring the optical density of 
each culture at 560 nm (OD560). The cell growth rate in the presence of each 
prebiotic was calculated according to the following formula:  
 
Growth rate = [((MRSp - MRSb)*100)/(MRSg - MRSb)]   (2) 
 
Where MRSp is the MRS containing each prebiotic, MRSb is the MRS without a 
carbon source (negative control) and MRSg is MRS containing glucose (positive 
control). 
 
In vivo safety evaluation 
 
Animals management and microorganism administration procedures  
 
BALB/c male mice, five to six weeks old, were provided by the Centro de 
Medicina Comparada, Instituto de Ciencias Veterinarias (ICiVet-Litoral), Faculty 
of Veterinary Sciences of the National University of Litoral (Esperanza, Santa 
Fe, Argentina). Prior to the beginning of the study, the project was submitted for 
evaluation and approved by the National University of Litoral Ethics and 
Research Committee. Twelve animals were used in the study. Animals were kept 
for 1 week in the animal facility at the Instituto de Lactología industrial (UNL-
CONICET) for acclimatization, at 21 ± 1 ° C, in 12h/12h light/dark cycle, with 
total air renewal rates of 20 volumes/h and ad libitum access to a standard rodent 
diet (Cooperación, Buenos Aires, Argentina) and sterile tap water. 
Bacterial translocation assay 
 
The mice were divided into 3 groups, each group comprising 4 animals. For 10 
consecutive days, mice received 0.3 ml/day of a cell suspension of L. rhamnosus 
64 (group 1), L. paracasei LP11 (group 2) or a sterile saline solution (control 
group). The cell suspension contained 107 CFU/mL of lactobacilli. After 10 days 
of administration, mice were anesthetized with a ketamine, xylazine and 
acepromazine cocktail and sacrificed by cervical dislocation. 
 
Liver and spleen were aseptically removed, homogenized in PBS and plated (1 
mL) on MacConkey agar (Biokar, Beauvais, France) according to Vinderola et al. 
(2005). Plates were incubated at 37 °C for 48 h. Results were expressed as 
positive (presence of bacterial colonies on the plates) or negative (absence of 




Statistical analyses were performed in a fully randomized design and two 
replicates. Data were analyzed by analysis of variance (ANOVA) and Tukey Test 
using the Statistical Analysis System (SAS, 1995, version 9.1.3). The results were 
considered statistically significant when p ≤ 0.05. 
 
RESULTS AND DISCUSSION 
 
Lysozyme resistance  
 
The two evaluated strains presented satisfactory results regarding lysozyme 
resistance, with L. paracasei LP11 displaying higher resistance than L. 







rhamnosus 64 (p <0.05), as shown in Figure 1. After exposure for 120 minutes to 
the electrolytic solution at a 100 mg/l lysozyme dilution simulating in vivo saliva 
conditions, L. rhamnosus 64 showed a 1.8 log CFU/g decrease, while L. 




Figure 1 Survival of L. paracasei LP11 ( ) e L. rhamnosus 64 ( ) in CFU / 
mL after exposure for 120 minutes to the electrolytic solution containing 100 mg 
/ l lysozyme. 
 
Other authors have reported values close to those reported herein. Vizoso Pinto et 
al. (2006) also evaluated the resistance of L. johnsonii LA1 to lysozyme, 
exposing the microorganism for 60 minutes to a solution containing lysozyme at 
a similar concentration and detected a decrease of one logarithmic cycle in 
relation to the initial microorganism concentration. Zago et al. (2011) evaluated 
the lysozyme susceptibility of 27 L. plantarum strains isolated from cheeses. The 
results varied between 3.24 and 99.97% survival rates after 120 minutes of 
exposure to the solution containing 100 mg/l of lysozyme, and 15 strains showed 
survival above 68%, a result considered satisfactory by the authors. Kõll et al. 
(2008) evaluated the sensitivity of 22 lactobacilli strains specifically selected as 
probiotic candidates for oral health performance, and observed after determining 
the presence of growth inhibition zones that all strains were resistant to lysozyme 
at concentrations ranging from 0.2 to 10 mg/ml. 
Recently, some researchers have suggested the use of probiotics for oral health 
promotion (Bizzini et al., 2012; Haukioja, 2010), thus encouraging research to 
develop vehicles for probiotic delivery into the oral cavity. Some of the research 
published so far (Heinemann, Carvalho, & Favaro-Trindade, 2013; Saha, 
Tomaro-Duchesneau, Daoud, Tabrizian, & Prakash, 2013) propose the 
incorporation of probiotic bacteria in oral disintegration films, allowing the 
probiotics to comprise the transient microbiota of the buccal mucosa and teeth, 
permitting protective action against pathogenic microorganisms that promote 
dental diseases. For this type of study, probiotic sensitivity to lysozyme is crucial, 
since this enzyme has been shown to be effective in killing several types of 
Gram-positive bacteria by promoting cell wall rupture and subsequent cell lysis 
(Kõll et al., 2008).  
As observed in several studies, including the one conducted by Zago et al. 
(2011), lactobacilli sensitivity to lysozyme is a strain-dependent trait. When 
incorporated into a food product, the sensitivity of the microorganism to 
lysozyme is not as worrying, since exposure of the probiotic to the enzyme is 
very short. As seen herein, during the first 30 minutes, the impact of lysozyme on 
L. paracasei LP11 and L. rhamnosus 64 concentrations was very low. However, it 
is always prudent to assess such sensitivity, considering that there may be a 
deleterious summation of buccal secretion and gastrointestinal secretions. 
 
Resistance to simulated gastrointestinal fluids 
 
In order for the ingested probiotics to reach the intestinal lumen, their main site 
of action, they must be able to withstand adverse gastrointestinal (GIT). In order 
to have a physiological impact, it is desirable that probiotics reach the GIT in 
concentrations higher than 7 log CFU/g (Gill & Rutherfurd, 2001; Ya et al., 
2008). 
After exposure to gastrointestinal fluids, the behavior of L. paracasei LP11 and 
L. rhamnosus 64 was observed after 120 minutes exposure to simulated gastric 
fluid (p <0.05). While L. rhamnosus 64 showed a 1.31 log CFU/g decrease, the 
decrease of L. paracasei LP11 concentrations reached 3.37 log CFU/g (Fig. 2). 
However, the behavior of both strains in relation to exposure to simulated 
intestinal fluids for 90 minutes was not significantly different (p> 0.05), with no 
significant concentration decreases. After gastrointestinal fluid exposure, data 
indicated that L. rhamnosus 64 presented a final concentration of 6.05 log CFU/g, 
while L. paracasei LP11 presented a final concentration of 3.92 log CFU/g. 
 
 
Figure 2 Survival of L. paracasei LP11 ( ) e L. rhamnosus 64 ( ) in CFU / 
mL after 300 min exposure to simulated gastrointestinal fluids (SGF), with 120 
minutes of exposure in simulated gastric fluid and 180 minutes of exposure in 
simulated intestinal fluids (SIF). 
 
Significant decreases in the concentrations of viable lactobacilli cells exposed to 
gastrointestinal fluids have been reported by several authors.  Ilha, da Silva, 
Lorenz, de Oliveira Rocha, & Sant’Anna (2015) characterizing L. paracasei, 
reported a 4.25 log CFU/mL decrease after exposure to pH 2.0 for 3 hours. Ding 
& Shah (2007) evaluated the resistance of L. rhamnosus and L. paracasei at pH 
2.0 for 2 hours and reported a decrease of 6.69 and 6.61 log CFU/mL for each 
microorganism, respectively. Pimentel-González, Campos-Montiel, Lobato-
Calleros, Pedroza-Islas, & Vernon-Carter (2009) reported that L. rhamnosus 
when exposed under simulated gastric conditions at pH 2.3 for 2 hours presented 
a 1.87 log CFU/mL decrease in relation to initial concentrations. 
Some probiotic-candidate microorganisms may present high sensitivity to 
gastrointestinal fluids, but promising results in other characterization tests or 
when included in a food matrix. One way to overcome this high sensitivity is the 
use of microencapsulation technology, which has demonstrated satisfactory 
efficiency in increasing survival against GIT conditions (Bosnea et al., 2014; 
Cook et al., 2012; de Vos et al., 2010; Pedroso et al., 2012). Several 
microencapsulation techniques have been successfully applied in the protection 
of probiotic cells, with emphasis on spray chilling (Okuro, de Matos, & Favaro-
Trindade, 2013; Pedroso, Dogenski, Thomazini, Heinemann, & Favaro-Trindade, 
2013) and complex coacervation (Bosnea et al., 2014; Oliveira et al., 2007). In 
this context, although L. paracasei LP11 and L. rhamnosus 64 showed high 
sensitivity to gastrointestinal fluids, the use of the microencapsulation technology 
could be advantageous, depending on the results of the other probiotic potential 




Significant attention has been paid to cell wall hydrophobicity profiles in the 
characterization of microorganisms with probiotic potential. Although 
hydrophobicity is not the only factor related to the complex adhesion process of 
microorganisms to the intestinal epithelium, some authors state that the initial 
stage of this fixation is mediated by physico-chemical interactions that include 
hydrophobicity and chemical charges (Barbosa, Silva, Martins, & Nicoli, 2005; 
Pelletier et al., 1997). It is believed that the higher the hydrophobicity of the 
surface of the microorganism, the greater its adhesion capacity (Kos et al., 2003; 
Rosenberg, Gutnick, & Rosenberg, 1980). Although some studies claim that 
lactobacilli generally present a hydrophobic cell surface (García-Cayuela et al., 
2014), it is possible to find studies with varied hydrophobicity values, including 
values below 10% (Dhewa, Bajpai, Saxena, Pant, & Mishra, 2010; Zago et al., 
2011) and above 90% (Mangoni et al., 2011; Van Coillie et al., 2007). 
In the present study L. rhamnosus 64 presented 19.19% hydrophobicity, while L. 
paracasei LP11 presented 8.47%, within the range reported in the literature. 
Other studies that have also evaluated L. rhamnosus and L. paracasei strains 
support the claim that cell surface hydrophobicity profile, as well as several other 
characteristics expected for probiotic microorganisms, is strain-dependent. 
Pelletier et al. (1997) cites values between 8.3 and 9.6% and 8.7 and 26.5% 
hydrophobicity for L. paracasei and L. Rhamnosus strains, respectively, while 
Xu, Jeong, Lee, & Ahn (2009) reported hydrophobicity values close to 25 and 
46% for L. paracasei and L. rhamnosus GG, respectively. Polak-Berecka, Waśko, 
Paduch, Skrzypek, & Sroka-Bartnicka (2014) also used hexadecane as solvent to 







evaluate the hydrophobicity of L. rhamnosus and reported values between 11 and 
16%.  
It is important to note that, although it is desirable for a probiotic to have a 
hydrophobic outer surface, so that it is able to withstand the effects of intestinal 
peristalsis of the intestinal fluid stream and not be eliminated, this should not be a 
limiting feature in probiotic selection, since, as observed by Santos et al. (2016), 
probiotics with remarkable positive functional characteristics and low 
hydrophobicity are also available.  
 
Antibiotic susceptibility analysis 
 
The results of the antibiotic susceptibility analysis of the two evaluated 
lactobacilli strains are summarized in Table 1. L. rhamnosus 64 showed 
sensitivity to five of the eight evaluated antibiotics, presenting moderate 
sensitivity to penicillin and tetracycline and resistance to erythromycin. On the 
other hand, L. paracasei LP11 showed sensitivity to penicillin and moderate 
sensitivity to erythromycin and tetracycline. Both strains were resistant to 
vancomycin, which corroborates several studies, both recent (Aazami et al., 
2014; Haghshenas et al., 2015; Santos et al., 2016) and otherwise (Hamilton-
Miller & Shah, 1998). In summary, the resistance profile of L. rhamnosus 64 and 
L. paracasei LP11 to the evaluated antibiotics did not differ compared to reports 
published in the literature (Gueimonde, Sánchez, G. de los Reyes-Gavilán, & 
Margolles, 2013; Kõll et al., 2008; Santos et al., 2016; M. Sharma & Devi, 2014; 
Vizoso Pinto et al., 2006).  
 
Table 1  Antibiotic resistance profile of L. rhamnosus 64 and L. paracasei LP11 
Strains Antibiotics 
Cefe Cefo Ceft Eri Neo Pen Tet Van 
L. rhamnosus 64 S S S R S MS MS R 
L. paracasei LP11 S S S MS S S MS R 
Antibiotics: Cefepime (Cefe) (30 μg), cefoxitin (Cefo) (30 μg), ceftriaxone (Ceft) (30 μg), erythromycin (Eri) (15 μg), neomycin (Neo) (30 μg), 
penicillin (Pen) (10 μg), tetracycline (Tet) (30 μg) and vancomycin (Van) (30 μg). S: sensitive, MS: moderately sensitive, R: resistant. 
 
Probiotic resistance to antibacterial drugs does not necessarily motivate concerns; 
on the contrary, the use of resistant probiotics may be useful for the restoration of 
the intestinal microbiota after treatment with antibiotics (Gueimonde et al., 
2013). However, a problem arises when the resistance is transferable, allowing 
pathogenic microorganisms to acquire resistance through bacteria used as 
probiotics (Bernardeau, Vernoux, Henri-Dubernet, & Guéguen, 2008; P. Sharma, 
Tomar, Goswami, Sangwan, & Singh, 2014). The resistance of lactobacilli strains 
to erythromycin and vancomycin detected herein has been reported in the 
literature as an intrinsic resistance without the risk of horizontal transfer (Ammor, 
Belén Flórez, & Mayo, 2007; Gad, Abdel-Hamid, & Farag, 2014; Rabia & Shah, 
2011). 
 
In vitro antagonism 
 
L. paracasei LP11 and L. rhamnosus 64 were able to promote an antagonistic 
effect against the four evaluated pathogens (Escherichia coli V517, Salmonella 
enteritidis OMS-Ca, Staphylococcus aureus 76 and Listeria monocytogenes 
ATCC 15313). A pathogen growth inhibition zone greater than 6 mm was 
observed in all spots containing active lactobacilli cells (Table 2). No positive 
inhibition results regarding antagonist activity of the supernatants obtained from 
the growth of the lactobacillus strains neutralized with 5 M NaOH and boiled for 
5 minutes was detected, indicating that the inhibition observed by active cells 
was not due to the production of thermoresistant bacteriocins. Similar reports 
have been published by other authors evaluating lactobacilli strains 
(Maragkoudakis et al., 2006; Poppi et al., 2015; Vizoso Pinto et al., 2006). Those 
studies suggest that the antagonistic effect in this case is possibly due to the 
production of organic acids. This statement, however, is not unanimous in the 
literature. Santos et al., (2016), for example, reported that neutralized 
supernatants from lactobacillus isolates isolated from cocoa fermentation were 
able to inhibit E. coli ATCC 25922 growth, noting that L. plantarum supernatants 
also inhibited S. enterica var. Typhimurium ATTCC 14028 and Shiguella flexi 
ATTCC11060. 
 
Table 2 Evaluation of in vitro antagonism capacity of L. rhamnosus 64 and L. paracasei LP11 
Strains Pathogens 
EC SE AS LM 
L. rhamnosus 64 + + + + 
L. paracasei LP11 + + + + 
Microorganisms: Escherichia coli V517 (EC); Salmonella enteritidis OMS-Ca (SE); Staphylococcus aureus 76 (AS); Listeria monocytogenes 




Considering that prebiotics are non-digestible food ingredients capable of 
selectively stimulating probiotic growth (Gibson & Roberfroid, 1995), the 
evaluation of the probiotic microorganism capacity to use prebiotics is 
indispensable, especially when their use in symbiotic products is envisaged. 
Considering that recent research has demonstrated that the ability to use 
prebiotics is a strain-dependent trait (Mandadzhieva, Ignatova-Ivanova, 
Kambarev, Iliev, & Ivanova, 2011; Zago et al., 2011), the two lactobacilli strains 
studied herein were evaluated for their capacity to use four prebiotics: inulin, 
polydextrose, P95 rafthiosis and lactulose. As displayed in Figure 3, L. paracasei 
LP11 showed high growth in the presence of inulin and fructooligosaccharides, 
with cell growth rates of 75% and 86%, respectively, in relation to the control. 
However, this strain presented growth rates lower than 35% in the presence of 
polydextrose or lactulose. L. rhamnosus 64, on the other hand, presented high 
growth only in the presence of lactulose, of 91% in relation to the control, and 
cellular growth rate of less than 40% in the presence of the other evaluated 
prebiotics. When the growth performance of the two strains was evaluated in the 
presence of each prebiotic, inverse behaviors (p <0.05) were observed, except for 
polydextrose, which did not result in any growth difference between the two 
strains (p> 0.05). 
 
 
Figure 3 Use of inulin, lactulose, P95 rafthiosis and polydextrose by L. paracasei 
LP11 ( ) and L. rhamnosus 64 ( ) during growth. The Prebiotic Utilization 
Capacity (CUP) values were expressed as percentage of cell growth in relation to 
glucose (100% of use), used as control after 24 hours of incubation. 
 
 







Lactulose that, in this study, promoted a high growth rate for L. rhamnosus 64 
and low for L. paracasei LP11 was also the target of a study performed by Zago 
et al. (2011) regarding its use by 27 L. plantarum strains isolated from cheese. 
The authors reported that lactulose, among seven evaluated prebiotics, provided 
the highest cell growth rate for all the investigated strains, with values close to 
100% in relation to the control. Kunová, Rada, Lisova, Ročkova, & Vlková 
(2011) also reported successful results regarding the use of lactulose by several 
lactobacilli species, although inulin promoted the highest growth rates. Watson et 
al., (2013) observed satisfactory growth rates for 21 lactobacillus species when 
using lactulose, noting that the same strains were not able to use inulin and 
polydextrose.  
The studies available in the literature present mixed results, reinforcing the 
assertion that probiotic use of prebiotics is a strain-dependent characteristic 
(Tropcheva et al., 2013), and prevent any kind of generalization. However, a 
frequently reported behavior is the low capacity or inability of lactobacilli to use 
polydextrose (Mäkeläinen, Saarinen, Stowell, Rautonen, & Ouwehand, 2010; 
Watson et al., 2013; Zago et al., 2011), a fact corroborated by the findings 
reported herein, for both L. rhamnosus 64 and L. paracasei LP11. Polydextrose 
presents a complex structure, and is difficult and slow to degrade, requiring the 
performance of several intestinal microbiota microorganisms to promote at least 
partial molecular degradation (Röytiö & Ouwehand, 2014). Although results 
from in vitro tests with isolated probiotic microorganisms are not successful in 
terms of the ability to use polydextrose, it is important to note that some clinical 
studies have confirmed the ability of this prebiotic to beneficially modulate 
intestinal microbiota (Costabile et al., 2012; Hooda et al., 2012; Jie et al., 2000; 
Lamichhane et al., 2014). 
Inulin and fructooligosaccharides are among the most commonly used prebiotic 
ingredients for the development of symbiotic foods (Buriti, Cardarelli, Filisetti, & 
Saad, 2007; Fornelli et al., 2014; Moayednia, 2014; Paula K Okuro, Thomazini, 
Balieiro, Liberal, & Fávaro-Trindade, 2013; Paz, Oliveira, Kairuz, & Ramón, 
2014), although the ability of these probiotics to use these probiotic 
microorganisms is not always tested. With recognized bifidogenic effects 
(Búrigo, Fagundes, Trindade, & Vasconcelos, 2007; Shoaib et al., 2016), inulin 
and fructooligosaccharides have also demonstrated positive effects for 
lactobacilli. Souza Oliveira, Perego, de Oliveira e Converti (2012) reported 
satisfactory results regarding the effect of inulin on growth and metabolism of L. 
rhamnosus in co-culture with Streptococcus thermophilus. Makras, Van Acker e 
De Vuyst (2005) observed that Lactobacillus paracasei subsp. paracasei 8700: 2 
isolated from breast milk was able to use inulin and fructooligosaccharides. On 
the other hand, in the studies conducted by Adebola, Corcoran and Morgan 
(2014), L. acidophilus NCTC 1723, L. delbrueckii ssp. bulgaricus NCTC 12712 
and L. brevis NCIMB 11973 were not able to use inulin as a carbon source. 
It is pertinent to point out that the fact that a prebiotic does not stimulate the 
growth of the probiotic present in the symbiotic food does not mean that its 
activity is useless, since other strains belonging to the intestinal microbiota can 
be stimulated, promoting host benefits. However, it is strongly expected that the 
prebiotic should display the ability to stimulate the growth of the accompanying 
probiotic in a symbiotic food. 
 
In vivo safety evaluation 
 
No bacterial translocation to liver or spleen was observed for the dose of L. 
paracasei LP11 and L. rhamnosus 64 assessed, suggesting that these 
microorganisms did not alter the integrity of the intestinal epithelium or the 
balance of the resident microbiota. 
The translocation of bacteria from the enteric microbiota to extraintestinal sites 
due to microorganism administration is one of the most worrisome adverse 
effects of this practice. Considered a probiotic toxicity factor, bacterial 
translocation may be related to the pathogenesis process of opportunistic strains 
(Zago et al., 2011). Several authors have investigated the translocation possibility 
of probiotic-candidate lactobacilli strains. Medici, Vinderola, & Perdigón (2004) 
reported negative results for translocation when evaluating L. acidophilus and L. 
paracasei isolated from cheese. Similar results were reported by Zago et al. 
(2011) when evaluating the administration of L. plantarum strains derived from 
cheeses.  
In 2005, a study carried out by Vinderola et al. (2005) suggested that the 
possibility of bacterial translocation could be related to the dosage. When 
studying the immunomodulatory effect of kefir in mice, the authors verified the 
occurrence of bacterial translocation to spleen and liver when daily doses of kefir 
diluted at 1/10 and 1/50 ratios were administered. However, when the kefir was 
was administered at 1/100 and 1/200 ratios, bacterial translocation was negative. 
Gregoret, Perezlindo, Vinderola, Reinheimer, & Binetti (2013), who administered 
doses higher than the one evaluated herein, did not verify bacterial translocation 
at daily doses of 2 × 108 CFU for up to 7 days for L. paracasei, L. rhamnosus and 
L. gasseri isolated from newborn feces. As the risk of bacterial translocation may 
correlate with dosage, it is important to perform oral ingestion safety tests as a 






The in vitro evaluation performed herein revealed that the two lactobacilli strains 
presented satisfactory results in most of the conducted tests, demonstrating 
potential for use as probiotic microorganisms in functional foods. The analysis of 
resistance to gastrointestinal conditions was the only feature that fell short of the 
desired. However, such resistance can be improved by microencapsulation 
technology, which has shown promising results. In the safety test performed in 
vivo, the ingestion of both strains was shown to be safe at the dosage 
administered in an animal model. Once resistance to gastrointestinal conditions 
has been improved, the microorganisms must undergo in vivo tests in order to 
determine their possible functionalities in the organism, to be subsequently 
applied in a food matrix. 
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